title: The enhancement of contextual fear conditioning by ABT-418.
abstract: Activation of nicotinic acetylcholine receptors (nAChRs) is known to modulate various forms of learning and memory, including contextual fear conditioning. Although numerous studies have shown that high-affinity beta2-containing nAChRs are necessary for the nicotine-induced enhancement of contextual fear conditioning, it is unknown whether other high-affinity nAChR agonists are capable of enhancing this learning. To examine this issue, ABT-418, a high-affinity nAChR agonist with greater selectivity for high-affinity receptors than nicotine, was administered before acquisition and/or recall of contextual fear memories. ABT-418 enhanced acquisition of contextual fear memories in a dose-dependent manner.
authors.affiliation: Department of Psychology, Temple University, Philadelphia, Pennsylvania 19122, USA.
authors.forename: Justin W
authors.initials: JW
authors.lastname: Kenney
authors.forename: Derek S
authors.initials: DS
authors.lastname: Wilkinson
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Gould
mesh_terms: D000161:Acoustic Stimulation / Q000009:adverse effects; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001703:Biophysics; D003214:Conditioning, Classical / Q000187:drug effects*; D004597:Electroshock / Q000009:adverse effects; D005239:Fear / Q000187:drug effects*; D007555:Isoxazoles / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology*; D018709:Statistics, Nonparametric; D014828:Vocalization, Animal / Q000187:drug effects
chemical_list: D014151:Anti-Anxiety Agents; D007555:Isoxazoles; D011759:Pyrrolidines; C088383:3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole
references.citation: Am J Psychiatry. 1999 Dec;156(12):1931-7
references.pmid: 10588407
references.citation: J Pharmacol Exp Ther. 1997 Mar;280(3):1117-36
references.pmid: 9067295
references.citation: J Neurosci. 1991 Mar;11(3):837-45
references.pmid: 1705971
references.citation: Behav Neurosci. 2008 Oct;122(5):1158-65
references.pmid: 18823171
references.citation: J Med Chem. 1997 Dec 19;40(26):4169-94
references.pmid: 9435889
references.citation: Brain Res Mol Brain Res. 1992 Dec;16(3-4):339-44
references.pmid: 1337943
references.citation: Psychopharmacology (Berl). 1999 May;144(2):175-82
references.pmid: 10394999
references.citation: Neuropharmacology. 2003 Jun;44(8):1054-67
references.pmid: 12763099
references.citation: Acta Pharmacol Sin. 2009 Jun;30(6):752-60
references.pmid: 19434057
references.citation: Psychopharmacology (Berl). 1999 Mar;142(4):334-42
references.pmid: 10229057
references.citation: Br J Pharmacol. 1997 Feb;120(3):429-38
references.pmid: 9031746
references.citation: Neuropsychopharmacology. 2009 Aug;34(9):2167-79
references.pmid: 19404242
references.citation: Psychopharmacology (Berl). 2007 Feb;190(3):343-52
references.pmid: 17136517
references.citation: Rev Physiol Biochem Pharmacol. 2003;147:1-46
references.pmid: 12783266
references.citation: Psychopharmacology (Berl). 1997 Apr;130(3):276-84
references.pmid: 9151363
references.citation: Psychopharmacology (Berl). 1998 Mar;136(1):50-8
references.pmid: 9537682
references.citation: Annu Rev Physiol. 1995;57:521-46
references.pmid: 7778876
references.citation: Science. 1992 May 1;256(5057):675-7
references.pmid: 1585183
references.citation: J Comp Neurol. 1989 Jun 8;284(2):314-35
references.pmid: 2754038
references.citation: Mol Neurobiol. 2008 Aug;38(1):101-21
references.pmid: 18690555
references.citation: J Physiol. 1994 Nov 15;481 ( Pt 1):27-34
references.pmid: 7853248
references.citation: Neuroscience. 2004;129(1):11-24
references.pmid: 15489024
references.citation: Neurosci Biobehav Rev. 2004 Nov;28(7):675-85
references.pmid: 15555677
references.citation: J Pharmacol Exp Ther. 1994 Jul;270(1):319-28
references.pmid: 7913497
references.citation: Neuropharmacology. 2009 Jan;56(1):237-46
references.pmid: 18723036
references.citation: Behav Brain Res. 2004 Nov 5;155(1):167-73
references.pmid: 15325790
references.citation: J Pharmacol Exp Ther. 1994 Jul;270(1):310-8
references.pmid: 7518514